Zimmer Expands Portfolio of Foot and Ankle, Hand and Wrist Technologies through Addition of Innovative Small Bone Specialty Company
WARSAW, Ind., June 4, 2013 /PRNewswire/ — Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH) announced today that it has acquired Tuttlingen, Germany-based NORMED Medizin-Technik GmbH, a provider of innovative technologies for the foot and ankle, hand and wrist reconstruction and trauma markets.
NORMED develops a broad range of specialized plates, screws and instruments, including systems for bone reconstruction and fracture repair, fusion procedures and external fixation. The acquisition of NORMED will strengthen Zimmer’s Extremities and Trauma product portfolios and new product development capabilities in the fast growing foot and ankle and hand and wrist segments.
About Zimmer Holdings, Inc.
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer’s 2012 sales were approximately $4.5 billion. The Company is supported by the efforts of more than 8,500 employees worldwide.
About NORMED Medizin-Technik GmbH
Founded in 1988 and located in Tuttlingen, Germany, Normed Medizin-Technik GmbH is an innovative global medical company that provides a broad range of plates, screws and specialized instruments for foot and ankle and hand and wrist surgeries.
Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management’s beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as “may,” “will,” “expects,” “believes,” “anticipates,” “plans,” “estimates,” “projects,” “assumes,” “guides,” “targets,” “forecasts,” and “seeks” or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.
SOURCE Zimmer Holdings, Inc.
News Provided by Acquire Media